InsiderSource
RXST

RxSight, Inc.

SEC CIK 1111485
$4.71 −40.7% · 90 days
90-day buys
$0
0 open-market
90-day sells
$0
0 open-market
Net insider flow
+$0
Net buying
Filings shown
46
Most recent
Advertisement

At a glance

Insiders at RXST have made no open-market trades in the last 90 days — the activity below is grants, option exercises, and other routine filings.

Largest recent trade: Thunen Shelley B sold $1.5M of RXST, trimming their stake 82%.

Most active filer: Thunen Shelley B, with 27 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for RXST, newest first
View on SEC EDGAR ↗
RXST
RxSight, Inc.
Option exercise Goldshleger Ilya · Chief Operating Officer · Option exercise · filed Apr 20, 2026 ΔOwn +19%
+$51.6K
12,489 sh @ $4
RXST
RxSight, Inc.
Option exercise Wilterding Mark · Chief Financial Officer · Option exercise · filed Mar 3, 2026 ΔOwn NEW
+$0
20,441 sh
RXST
RxSight, Inc.
Tax withholding Wilterding Mark · Chief Financial Officer · Tax withholding · filed Mar 3, 2026 ΔOwn −39%
−$61.4K
8,068 sh @ $8
RXST
RxSight, Inc.
Option exercise Gaines Scott · Chief Customer Officer · Option exercise · filed Mar 3, 2026 ΔOwn +56%
+$0
6,261 sh
RXST
RxSight, Inc.
Tax withholding Gaines Scott · Chief Customer Officer · Tax withholding · filed Mar 3, 2026 ΔOwn −15%
−$19.6K
2,580 sh @ $8
Advertisement
RXST
RxSight, Inc.
Option exercise Weinberg Eric · See remarks · Option exercise · filed Jun 3, 2025 ΔOwn +999%
+$738.8K
188,002 sh @ $4
RXST
RxSight, Inc.
Sell Fountain Tamara · Director · Open-market sale · filed Mar 13, 2025 ΔOwn −22%

Fountain Tamara sold $180K of RXST, trimming their stake 22%.

−$180K
7,000 sh @ $26
RXST
RxSight, Inc.
Sell Maniar Shweta · Director · Open-market sale · filed Jan 27, 2025 ΔOwn −32%

Maniar Shweta sold $108.6K of RXST, trimming their stake 32%.

−$108.6K
3,519 sh @ $31
RXST
RxSight, Inc.
Sell Thunen Shelley B · See remarks · Open-market sale · filed Oct 2, 2024 ΔOwn −11%

Thunen Shelley B sold $249.4K of RXST, trimming their stake 11%.

−$249.4K
5,201 sh @ $48
RXST
RxSight, Inc.
Sell Thunen Shelley B · See remarks · Open-market sale · filed Oct 2, 2024 ΔOwn −24%

Thunen Shelley B sold $463.6K of RXST, trimming their stake 24%.

−$463.6K
9,521 sh @ $49
RXST
RxSight, Inc.
Sell Thunen Shelley B · See remarks · Open-market sale · filed Oct 2, 2024 ΔOwn −0.9%

Thunen Shelley B sold $13.7K of RXST, trimming their stake 1%.

−$13.7K
278 sh @ $49
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Jul 2, 2024 ΔOwn −34%

Thunen Shelley B sold $475.8K of RXST, trimming their stake 34%.

−$475.8K
8,146 sh @ $58
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Jul 2, 2024 ΔOwn −12%

Thunen Shelley B sold $110.3K of RXST, trimming their stake 12%.

−$110.3K
1,854 sh @ $59
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Jul 2, 2024 ΔOwn −79%

Thunen Shelley B sold $386.4K of RXST, trimming their stake 79%.

−$386.4K
6,599 sh @ $59
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Jul 2, 2024 ΔOwn −100%

Thunen Shelley B sold $107.4K of RXST, trimming their stake 100%.

−$107.4K
1,803 sh @ $60
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed May 2, 2024 ΔOwn −40%

Thunen Shelley B sold $506.8K of RXST, trimming their stake 40%.

−$506.8K
9,620 sh @ $53
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed May 2, 2024 ΔOwn −2.7%

Thunen Shelley B sold $20.2K of RXST, trimming their stake 3%.

−$20.2K
380 sh @ $53
RXST
RxSight, Inc.
Sell Thunen Shelley B · Chief Financial Officer · Open-market sale · filed Apr 2, 2024 ΔOwn −31%

Thunen Shelley B sold $441.2K of RXST, trimming their stake 31%.

−$441.2K
8,857 sh @ $50
Advertisement

About RXST insider activity

This page tracks every recent Form 4 filed for RxSight, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is RXST insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for RxSight, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.